You are here

  • Home
  • Archive
  • Volume 5, Issue 8
  • Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

Citation Tools

Article menu

Download PDFPDF

XML
Gastroenterology and hepatology
Protocol
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ong SY, Dolling L, Dixon JL, et al
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)
BMJ Open 2015;5:e008938. doi: 10.1136/bmjopen-2015-008938